ScreenerHero

ARTL Artelo Biosciences, Inc.

NAS · US · Healthcare · Biotechnology · artelobio.com
3.410USD-1.45%Mkt Cap: 1.87M $P/E: —

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap1.87M USD
Enterprise Value-2.38M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-12.88M USD
Revenue/Share—
Last Price3.410 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.93
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.32
EPS (TTM)-136.26
EPS (Forward)-0.88
52W Range
3.3320% of range179.19
52W High179.19 USD
52W Low3.332 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE1012.50%
ROA-459.80%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.52M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-458.94%
Net Debt-4.15M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.53
Current Ratio3.00
Quick Ratio2.88
Book Value/Sh10.74 USD
Cash/Share8.22 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 21, 2019
Splits
Last Split1:9
Split DateAug 31, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.547.77K
Float510.24K
Insiders0.11%
Institutions2.38%
Short Interest
Short Ratio0.2d
Short % Float4.12%
Short % Out.4.12%
Shares Short22.55K
Short (prev mo.)9.48K
Technical
SMA 505.853 (-41.7%)
SMA 20025.29 (-86.5%)
Beta-0.07
S&P 52W Chg16.45%
Avg Vol (30d)949.74K
Avg Vol (10d)2.73M
Technical Indicators
RSI (14)35.7
MACD-0.8245
MACD Signal-0.7795
MACD Hist.-0.0451
BB Upper6.767 USD
BB Middle4.647 USD
BB Lower2.528 USD
BB Width91.23%
ATR (14)0.9439 USD
Vol Ratio (20d)0.04x